XML 31 R20.htm IDEA: XBRL DOCUMENT v3.4.0.3
Derivative Financial Instruments (Tables)
3 Months Ended
Apr. 03, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule Of Fair Values Of The Company's Derivative Instruments And The Line Items On The Consolidated Balance Sheets
The fair values of the Company’s derivative instruments and the line items on the unaudited condensed consolidated balance sheets to which they were recorded as of April 3, 2016 and December 31, 2015 are summarized as follows (in thousands):
Derivative Assets
 
Balance Sheet
Location
 
Fair Value at
April 3, 2016
 
Balance Sheet
Location
 
Fair Value at
December 31, 2015
Derivative assets not designated as hedging instruments
 
Prepaid expenses and other current assets
 
$
463

 
Prepaid expenses and other current assets
 
$
3,203

Derivative assets designated as hedging
instruments
 
Prepaid expenses and other current assets
 

 
Prepaid expenses and other current assets
 
2

Total
 
 
 
$
463

 
 
 
$
3,205


 
Derivative Liabilities
 
Balance Sheet
Location
 
Fair Value at
April 3, 2016
 
Balance Sheet
Location
 
Fair Value at
December 31, 2015
Derivative liabilities not designated as hedging instruments
 
Other accrued liabilities
 
$
3,106

 
Other accrued liabilities
 
$
447

Derivative liabilities designated as hedging instruments
 
Other accrued liabilities
 
443

 
Other accrued liabilities
 
4

Total
 
 
 
$
3,549

 
 
 
$
451

Schedule of Offsetting of Derivative Assets
The following tables set forth the offsetting of derivative assets as of April 3, 2016 and December 31, 2015 (in thousands):
As of April 3, 2016
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Assets
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts Of Assets Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
Wells Fargo
 
$
463

 
$

 
$
463

 
$
(463
)
 
$

 
$

Total
 
$
463

 
$

 
$
463

 
$
(463
)
 
$

 
$


As of December 31, 2015
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Assets
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts Of Assets Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
Barclays        
 
$
577

 
$

 
$
577

 
$
(56
)
 
$

 
$
521

Wells Fargo
 
2,628

 

 
2,628

 
(395
)
 

 
2,233

Total
 
$
3,205

 
$

 
$
3,205

 
$
(451
)
 
$

 
$
2,754

Schedule of Offsetting of Derivative Liabilities
The following tables set forth the offsetting of derivative liabilities as of April 3, 2016 and December 31, 2015 (in thousands):
As of April 3, 2016
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts Of Liabilities Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
JP Morgan Chase
 
$
28

 
$

 
$
28

 
$

 
$

 
$
28

Wells Fargo
 
3,521

 

 
3,521

 
(463
)
 

 
3,058

Total
 
$
3,549

 
$

 
$
3,549

 
$
(463
)
 
$

 
$
3,086


As of December 31, 2015
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts Of Liabilities Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
Barclays        
 
$
56

 
$

 
$
56

 
$
(56
)
 
$

 
$

Wells Fargo
 
395

 

 
395

 
(395
)
 

 

Total
 
$
451

 
$

 
$
451

 
$
(451
)
 
$

 
$

Schedule Of Company's Derivative Instruments On Other Comprehensive Income And The Consolidated Statement Of Operations
The effects of the Company’s derivative instruments on OCI and the unaudited condensed consolidated statement of operations for the three months ended April 3, 2016 and March 29, 2015 are summarized as follows (in thousands):
Derivatives Designated as Hedging Instruments
 
Three Months Ended April 3, 2016
 
Gain (Loss)
Recognized in
OCI -
Effective
Portion (a)
 
Location of
Gain (Loss)
Reclassified from OCI
into Income - Effective
Portion
 
Gain (Loss)
Reclassified
from
OCI into
Income -
Effective
Portion (a)
 
Location of
Gain (Loss)
Recognized in
Income and
Excluded from
Effectiveness  Testing
 
Amount of Gain (Loss) Recognized in
Income and
Excluded from
Effectiveness Testing
Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
(787
)
 
Net revenue
 
$
(312
)
 
Other income (expense), net
 
$
35

Foreign currency forward contracts
 

 
Cost of revenue
 
2

 
Other income (expense), net
 

Foreign currency forward contracts
 

 
Operating expenses
 
70

 
Other income (expense), net
 

Total
 
$
(787
)
 
 
 
$
(240
)
 
 
 
$
35

(a)
Refer to Note 8, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.

 
Derivatives Designated as Hedging Instruments
 
Three Months Ended March 29, 2015
 
Gain (Loss)
Recognized in
OCI -
Effective
Portion (a)
 
Location of
Gain (Loss)
Reclassified from OCI
into Income - Effective
Portion
 
Gain (Loss)
Reclassified
from
OCI into
Income -
Effective
Portion (a)
 
Location of
Gain (Loss)
Recognized in
Income and
Excluded from
Effectiveness  Testing
 
Amount of Gain (Loss) Recognized in
Income and
Excluded from
Effectiveness Testing
Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
(195
)
 
Net revenue
 
$
(147
)
 
Other income (expense), net
 
$
(19
)
Foreign currency forward contracts
 

 
Cost of revenue
 
(1
)
 
Other income (expense), net
 

Foreign currency forward contracts
 

 
Operating expenses
 
(23
)
 
Other income (expense), net
 

Total
 
$
(195
)
 
 
 
$
(171
)
 
 
 
$
(19
)

(a)
Refer to Note 8, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.

Schedule Of Derivatives Not Designated As Hedging Instruments
The effects of the Company’s non-designated hedged included in other income (expense), net in the unaudited condensed consolidated statements of operations for the three months ended April 3, 2016 and March 29, 2015 are as follows (in thousands):
Derivatives Not Designated as Hedging Instruments
 
Location of Gains (Losses)
Recognized in Income on Derivative
 
Amount of Gains (Losses)
Recognized in Income
 
Three Months Ended
 
April 3, 2016
 
March 29, 2015
Foreign currency forward contracts
 
Other income (expense), net
 
$
(1,944
)
 
$
3,843